Fusogenic liposome can be used as an effective vaccine carrier for peptide vaccination to induce cytotoxic T lymphocyte (CTL) response

10Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

We reported previously that fusogenic liposome (FL) introduced antigen protein encapsulated in the liposome directly into the cytoplasm of the antigen presenting cells, and that it induced immune responses. In the present study, we encapsulated TAX38-46, an HTLV-I derived protein and an antigen peptide model, into FL. The ability to induce effective cytotoxic T lymphocytes (CTL) responses in immunized mice was evaluated. Results showed FL could induce CTL response effectively and suggested that FL is a potential peptide vaccine carrier. © 2005 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Sugita, T., Yoshikawa, T., Gao, J. Q., Shimokawa, M., Oda, A., Niwa, T., … Nakagawa, S. (2005). Fusogenic liposome can be used as an effective vaccine carrier for peptide vaccination to induce cytotoxic T lymphocyte (CTL) response. Biological and Pharmaceutical Bulletin, 28(1), 192–193. https://doi.org/10.1248/bpb.28.192

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free